Notice of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on convening the 4th Extraordinary General Meeting of Shareholders in 2024

SZSI · Nov 16

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.